Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2′-O-ribose methyltransferase

References

• Abraham, M. J., Lindahl, D., van der Spoel, E., Hess, B., & the GROMACS development team. (2014). GROMACS User Manual version, 5(2), 1–298.
   Google Scholar
• Ambure, P., Bhat, J., Puzyn, T., & Roy, K. (2019). Identifying natural compounds as multi-target-directed ligands against Alzheimer’s disease: An in silico approach. Journal of Biomolecular Structure and Dynamics, 37(5), 1282–1306. doi:10.1080/07391102.2018.1456975
   PubMed Web of Science ®Google Scholar
• Amera, G. M., Khan, R. J., Pathak, A., Jha, R. K., Muthukumaran, J., & Singh, A. K. (2019). Screening of promising molecules against MurG as drug target in multi-drug-resistant-Acinetobacter baumannii – Insights from comparative protein modeling, molecular docking and molecular dynamics simulation. Journal of Biomolecular Structure and Dynamics, 1–23. doi:10.1080/07391102.2019.1700167
   PubMed Web of Science ®Google Scholar
• Amera, G. M., Khan, R. J., Pathak, A., Kumar, A., & Singh, A. K. (2019). Structure based in-silico study on UDP-N-acetylmuramoyl-L-alanyl-D-glutamate-2,6-diaminopimelate ligase (MurE) from Acinetobacter baumannii as a drug target against nosocomial infections. Informatics in Medicine Unlocked, 16, 100216. doi:10.1016/j.imu.2019.100216
   Google Scholar
• Benkert, P., Biasini, M., & Schwede, T. (2011). Toward the estimation of the absolute quality of individual protein structure models. Bioinformatics, 27(3), 343–350. doi:10.1093/bioinformatics/btq662
   PubMed Web of Science ®Google Scholar
• Berendsen, H. J. C., Grigera, J. R., & Straatsma, T. P. (1987). The missing term in effective pair potentials. The Journal of Physical Chemistry, 91(24), 6269–6271. doi:10.1021/j100308a038
   Web of Science ®Google Scholar
• Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., & Bourne, P. E. (2000). The Protein Data Bank. Nucleic Acids Research, 28(1), 235–242. doi:10.1093/nar/28.1.235
   PubMed Web of Science ®Google Scholar
• Bordoli, L., Kiefer, F., Arnold, K., Benkert, P., Battey, J., & Schwede, T. (2009). Protein structure homology modeling using SWISS-MODEL workspace. Nature Protocols, 4(1), 1–13. doi:10.1038/nprot.2008.197
   PubMed Web of Science ®Google Scholar
• Cahn, P., Pozniak, A. L., Mingrone, H., Shuldyakov, A., Brites, C., Andrade-Villanueva, J. F., Richmond, G., Buendia, C. B., Fourie, J., Ramgopal, M., Hagins, D., Felizarta, F., Madruga, J., Reuter, T., Newman, T., Small, C. B., Lombaard, J., Grinsztejn, B., Dorey, D., … Min, S. (2013). Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: Week 48 results from the randomised, double-blind, non-inferiority SAILING study. The Lancet, 382(9893), 700–708. doi:10.1016/S0140-6736(13)61221-0
   PubMed Web of Science ®Google Scholar
• Camacho, C., Coulouris, G., Avagyan, V., Ma, N., Papadopoulos, J., Bealer, K., & Madden, T. L. (2009). BLAST+: Architecture and applications. BMC Bioinformatics, 10(1), 421. doi:10.1186/1471-2105-10-421
   PubMed Web of Science ®Google Scholar
• Carrion, A. F., Gutierrez, J., & Martin, P. (2014). New antiviral agents for the treatment of hepatitis C: ABT-450. Expert Opinion on Pharmacotherapy, 15(5), 711–716. doi:10.1517/14656566.2014.889116
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (2020). Severe outcomes among patients with coronavirus disease 2019 (COVID-19) — United States, February 12–March 16, 2020.
   Google Scholar
• Chen, H., Wei, P., Huang, C., Tan, L., Liu, Y., & Lai, L. (2006). Only one protomer is active in the dimer of SARS 3C-like proteinase. Journal of Biological Chemistry, 281(20), 13894–13898. doi:10.1074/jbc.M510745200
   PubMed Web of Science ®Google Scholar
• Chen, Y., Su, C., Ke, M., Jin, X., Xu, L., Zhang, Z., Wu, A., Sun, Y., Yang, Z., Tien, P., Ahola, T., Liang, Y., Liu, X., & Guo, D. (2011). Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2’-O-methylation by nsp16/nsp10 protein complex. PLoS Pathogens, 7(10), e1002294. doi:10.1371/journal.ppat.1002294
   PubMed Web of Science ®Google Scholar
• Chiu, S.-W., Pandit, S. A., Scott, H. L., & Jakobsson, E. (2009). An improved united atom force field for simulation of mixed lipid bilayers. The Journal of Physical Chemistry B, 113(9), 2748–2763. doi:10.1021/jp807056c
   PubMed Web of Science ®Google Scholar
• Colovos, C., & Yeates, T. O. (1993). Verification of protein structures: Patterns of nonbonded atomic interactions. Protein Science, 2(9), 1511–1519. doi:10.1002/pro.5560020916
   PubMed Web of Science ®Google Scholar
• de Wilde, A. H., Snijder, E. J., Kikkert, M., & van Hemert, M. J. (2018). Host factors in coronavirus replication. Current Topics in Microbiology and Immunology, 419, 1–42. doi:10.1007/82_2017_25
   PubMed Web of Science ®Google Scholar
• Feld, J. J., Moreno, C., Trinh, R., Tam, E., Bourgeois, S., Horsmans, Y., Elkhashab, M., Bernstein, D. E., Younes, Z., Reindollar, R. W., Larsen, L., Fu, B., Howieson, K., Polepally, A. R., Pangerl, A., Shulman, N. S., & Poordad, F. (2016). Sustained virologic response of 100% in HCV genotype 1b patients with cirrhosis receiving ombitasvir/paritaprevir/r and dasabuvir for 12weeks. Journal of Hepatology, 64(2), 301–307. doi:10.1016/j.jhep.2015.10.005
   PubMed Web of Science ®Google Scholar
• Gimeno, A., Ojeda-Montes, M., Tomás-Hernández, S., Cereto-Massagué, A., Beltrán-Debón, R., Mulero, M., Pujadas, G., & Garcia-Vallvé, S. (2019). The light and dark sides of virtual screening: What is there to know? International Journal of Molecular Sciences, 20(6), 1375. doi:10.3390/ijms20061375
   PubMed Web of Science ®Google Scholar
• Hospital, A., Goñi, J. R., Orozco, M., & Gelpí, J. L. (2015). Molecular dynamics simulations: Advances and applications. Advances and Applications in Bioinformatics and Chemistry, 8, 37–47. doi:10.2147/AABC.S70333
   Google Scholar
• Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., … Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395(10223), 497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Johns Hopkins CSSE. (2020). Coronavirus COVID-19 global cases by Johns Hopkins CSSE. Retrieved March 28, 2020 from https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6
   Google Scholar
• Kitchen, D. B., Decornez, H., Furr, J. R., & Bajorath, J. (2004). Docking and scoring in virtual screening for drug discovery: Methods and applications. Nature Reviews Drug Discovery, 3(11), 935–949. doi:10.1038/nrd1549
   PubMed Web of Science ®Google Scholar
• Ko, J., Park, H., Heo, L., & Seok, C. (2012). GalaxyWEB server for protein structure prediction and refinement. Nucleic Acids Research, 40(W1), W294–W297. doi:10.1093/nar/gks493
   PubMed Web of Science ®Google Scholar
• Krieger, E., Joo, K., Lee, J., Lee, J., Raman, S., Thompson, J., Tyka, M., Baker, D., & Karplus, K. (2009). Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: Four approaches that performed well in CASP8. Proteins: Structure, Function, and Bioinformatics, 77(S9), 114–122. doi:10.1002/prot.22570
   PubMed Web of Science ®Google Scholar
• Laskowski, R. A., Jabłońska, J., Pravda, L., Vařeková, R. S., & Thornton, J. M. (2018). PDBsum: Structural summaries of PDB entries. Protein Science., 27(1), 129–134. doi:10.1002/pro.3289
   PubMed Web of Science ®Google Scholar
• Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993). PROCHECK: A program to check the stereochemical quality of protein structures. Journal of Applied Crystallography, 26(2), 283–291. doi:10.1107/S0021889892009944
   Web of Science ®Google Scholar
• Lugari, A., Betzi, S., Decroly, E., Bonnaud, E., Hermant, A., Guillemot, J.-C., Debarnot, C., Borg, J.-P., Bouvet, M., Canard, B., Morelli, X., & Lécine, P. (2010). Molecular mapping of the RNA cap 2’-O-methyltransferase activation interface between severe acute respiratory syndrome coronavirus nsp10 and nsp16. Journal of Biological Chemistry, 285(43), 33230–33241. doi:10.1074/jbc.M110.120014
   PubMed Web of Science ®Google Scholar
• Luthy, R., Bowie, J. U., & Eisenberg, D. (1992). Assessment of protein models with three-dimensional profiles. Nature, 356(6364), 83–85. doi:10.1038/356083a0
   PubMed Web of Science ®Google Scholar
• Madhav N., Oppenheim, B., & Gallivan, M. (2017). Disease control priorities: Improving health and reducing poverty (3rd ed.). The International Bank for Reconstruction and Development.
   Google Scholar
• Marklund, E. G., & Benesch, J. L. P. (2019). Weighing-up protein dynamics: The combination of native mass spectrometry and molecular dynamics simulations. Current Opinion in Structural Biology, 54, 50–58. doi:10.1016/j.sbi.2018.12.011
   PubMed Web of Science ®Google Scholar
• Markowitz, M., Nguyen, B.-Y., Gotuzzo, E., Mendo, F., Ratanasuwan, W., Kovacs, C., Prada, G., Morales-Ramirez, J. O., Crumpacker, C. S., Isaacs, R. D., Gilde, L. R., Wan, H., Miller, M. D., Wenning, L. A., & Teppler, H. (2007). Rapid and durable antiretroviral effect of the HIV-1 integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: Results of a 48-week controlled study. JAIDS Journal of Acquired Immune Deficiency Syndromes, 46(2), 125–133. doi:10.1097/QAI.0b013e318157131c
   PubMed Web of Science ®Google Scholar
• Menachery, V. D., Debbink, K., & Baric, R. S. (2014). Coronavirus non-structural protein 16: Evasion, attenuation, and possible treatments. Virus Research, 194, 191–199. doi:10.1016/j.virusres.2014.09.009
   PubMed Web of Science ®Google Scholar
• Menachery, V. D., Yount, B. L., Josset, L., Gralinski, L. E., Scobey, T., Agnihothram, S., Katze, M. G., & Baric, R. S. (2014). Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2’-o-methyltransferase activity. Journal of Virology, 88(8), 4251–4264. doi:10.1128/JVI.03571-13
   PubMed Web of Science ®Google Scholar
• Micheletti, C. (2013). Comparing proteins by their internal dynamics: Exploring structure-function relationships beyond static structural alignments. Physics of Life Reviews, 10(1), 1–26. doi:10.1016/j.plrev.2012.10.009
   PubMed Web of Science ®Google Scholar
• Pushpakom, S., Iorio, F., Eyers, P. A., Escott, K. J., Hopper, S., Wells, A., Doig, A., Guilliams, T., Latimer, J., McNamee, C., Norris, A., Sanseau, P., Cavalla, D., & Pirmohamed, M. (2019). Drug repurposing: Progress, challenges and recommendations. Nature Reviews Drug Discovery, 18(1), 41–58. doi:10.1038/nrd.2018.168
   PubMed Web of Science ®Google Scholar
• Ramachandran, G. N., Ramakrishnan, C., & Sasisekharan, V. (1963). Stereochemistry of polypeptide chain configurations. Journal of Molecular Biology, 7(1), 95–99. doi:10.1016/S0022-2836(63)80023-6
   PubMed Web of Science ®Google Scholar
• Sax, P. E., Pozniak, A., Montes, M. L., Koenig, E., DeJesus, E., Stellbrink, H.-J., Antinori, A., Workowski, K., Slim, J., Reynes, J., Garner, W., Custodio, J., White, K., SenGupta, D., Cheng, A., & Quirk, E. (2017). Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): A randomised, double-blind, multicentre, phase 3, non-inferiority trial. The Lancet, 390(10107), 2073–2082. doi:10.1016/S0140-6736(17)32340-1
   PubMed Web of Science ®Google Scholar
• Schuttelkopf, A. W., & van Aalten, D. M. (2004). PRODRG: A tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallographica Section D Biological Crystallography, 60(8), 1355–1363. doi:10.1107/S0907444904011679
   PubMedGoogle Scholar
• Su, S., Wong, G., Shi, W., Liu, J., Lai, A. C. K., Zhou, J., Liu, W., Bi, Y., & Gao, G. F. (2016). Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends in Microbiology., 24(6), 490–502. doi:10.1016/j.tim.2016.03.003
   PubMed Web of Science ®Google Scholar
• Sulkowski, M. S., Eron, J. J., Wyles, D., Trinh, R., Lalezari, J., Wang, C., Slim, J., Bhatti, L., Gathe, J., Ruane, P. J., Elion, R., Bredeek, F., Brennan, R., Blick, G., Khatri, A., Gibbons, K., Hu, Y. B., Fredrick, L., Schnell, G., … Podsadecki, T. (2015). Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: A randomized trial. JAMA, 313(12), 1223–1231. doi:10.1001/jama.2015.1328
   PubMed Web of Science ®Google Scholar
• Trott, O., & Olson, A. J. (2009). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461. doi:10.1002/jcc.21334
   Web of Science ®Google Scholar
• UCLA MBI. The structure analysis and verification server. Retrieved from https://servicesn.mbi.ucla.edu/SAVES/
   Google Scholar
• Walmsley, S. L., Antela, A., Clumeck, N., Duiculescu, D., Eberhard, A., Gutiérrez, F., Hocqueloux, L., Maggiolo, F., Sandkovsky, U., Granier, C., Pappa, K., Wynne, B., Min, S., & Nichols, G. (2013). Dolutegravir plus abacavir–lamivudine for the treatment of HIV-1 infection. New England Journal of Medicine, 369(19), 1807–1818. doi:10.1056/NEJMoa1215541
   PubMed Web of Science ®Google Scholar
• Waterhouse, A., Bertoni, M., Bienert, S., Studer, G., Tauriello, G., Gumienny, R., Heer, F. T., de Beer, T. A. P., Rempfer, C., Bordoli, L., Lepore, R., & Schwede, T. (2018). SWISS-MODEL: Homology modelling of protein structures and complexes. Nucleic Acids Research, 46(W1), W296–W303. doi:10.1093/nar/gky427
   PubMed Web of Science ®Google Scholar
• Weiss, S. R., & Leibowitz, J. L. (2011). Coronavirus pathogenesis. Advances in Virus Research, 81, 85–164. doi:10.1016/b978-0-12-385885-6.00009-2
   PubMed Web of Science ®Google Scholar
• Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., Assempour, N., Iynkkaran, I., Liu, Y., Maciejewski, A., Gale, N., Wilson, A., Chin, L., Cummings, R., Le, D., … Wilson, M. (2018). DrugBank 5.0: A major update to the DrugBank database for 2018. Nucleic Acids Research, 46(D1), D1074–D1082. doi:10.1093/nar/gkx1037
   PubMed Web of Science ®Google Scholar
• World Health Organization (2003, December). Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Retrieved March 28, 2020 from http://www.who.int/csr/sars/country/table2004_04_21/en/index.html
   Google Scholar
• World Health Organization. (2019, November). Middle East respiratory syndrome coronavirus (MERS-CoV). Retrieved March 28, 2020 from https://www.who.int/emergencies/mers-cov/en/
   Google Scholar
• World Health Organization. (2020a). Naming the coronavirus disease (COVID-19) and the virus that causes it. Retrieved March 28, 2020 from https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it
   Google Scholar
• World Health Organization. (2020b). WHO Director-General’s opening remarks at the media briefing on COVID-19 – 3 March 2020. Retrieved March 28, 2020 from https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—3-march-2020
   Google Scholar
• World Health Organization. (2020c). WHO Director-General’s opening remarks at the media briefing on COVID-19 – 11 March 2020. Retrieved March 28, 2020 from https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020
   Google Scholar
• World Health Organization. (2020d). WHO Director-General’s opening remarks at the media briefing on COVID-19 – 18 March 2020. Retrieved March 28, 2020.
   Google Scholar
• World Health Organization. (2020e). Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Retrieved March 28, 2020 from https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)
   Google Scholar
• Yang, H., Yang, M., Ding, Y., Liu, Y., Lou, Z., Zhou, Z., Sun, L., Mo, L., Ye, S., Pang, H., Gao, G. F., Anand, K., Bartlam, M., Hilgenfeld, R., & Rao, Z. (2003). The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proceedings of the National Academy of Sciences of Sciences, 100(23), 13190–13195. doi:10.1073/pnas.1835675100
   PubMed Web of Science ®Google Scholar
• Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F., & Tan, W. (2020). A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine, 382, 727–733. doi:10.1056/NEJMoa2001017
   PubMed Web of Science ®Google Scholar